Datasets:
jarrydmartinx
/
support2

Dataset card Data Studio Files
xet
Community
age
float64
18
102
sex
stringclasses
2 values
hospdead
int64
0
1
slos
int64
3
343
dzgroup
stringclasses
8 values
dzclass
stringclasses
4 values
num.co
int64
0
9
edu
float64
0
31
⌀
income
stringclasses
4 values
scoma
float64
0
100
⌀
charges
float64
1.17k
1.44M
⌀
totcst
float64
0
633k
⌀
totmcst
float64
-102.72
711k
⌀
avtisst
float64
1
83
⌀
race
stringclasses
5 values
sps
float64
0.2
99.2
⌀
aps
float64
0
143
⌀
surv2m
float64
0
0.97
⌀
surv6m
float64
0
0.95
⌀
hday
int64
1
148
diabetes
int64
0
1
dementia
int64
0
1
ca
stringclasses
3 values
prg2m
float64
0
1
⌀
prg6m
float64
0
1
⌀
dnr
stringclasses
3 values
dnrday
float64
-88
285
⌀
meanbp
float64
0
195
⌀
wblc
float64
0
200
⌀
hrt
float64
0
300
⌀
resp
float64
0
90
⌀
temp
float64
31.7
41.7
⌀
pafi
float64
12
890
⌀
alb
float64
0.4
29
⌀
bili
float64
0.1
63
⌀
crea
float64
0.1
21.5
⌀
sod
float64
110
181
⌀
ph
float64
6.83
7.77
⌀
glucose
float64
0
1.09k
⌀
bun
float64
1
300
⌀
urine
float64
0
9k
⌀
adlp
float64
0
7
⌀
adls
float64
0
7
⌀
sfdm2
stringclasses
5 values
adlsc
float64
0
7.07
event_times
int64
3
2.03k
event_indicators
int64
0
1
72.07397
male
0
6
CHF
COPD/CHF/Cirrhosis
2
13
$11-$25k
0
22,723
8,480.3125
8,194.16406
16
white
29.199219
56
0.670898
0.498962
2
0
0
no
0.6
0.2
no dnr
6
68
2.5
115
28
36
null
null
null
3.099609
132
null
null
48
500
0
3
no(M2 and SIP pres)
3
107
1
41.95499
female
0
44
ARF/MOSF w/Sepsis
ARF/MOSF
2
12
under $11k
0
495,977
108,496.188
106,087.125
36.5
white
31.597656
46
0.698975
0.608887
19
0
0
no
0.5
0.5
no dnr
44
68
22.296875
120
33
38.5
141
2.299805
1.799805
0.5
131
7.349609
102
10
2,656
null
3
no(M2 and SIP pres)
3
836
0
46.78699
male
0
38
ARF/MOSF w/Sepsis
ARF/MOSF
4
12
under $11k
44
494,827
124,453.375
127,801.062
41.5
hispanic
34.296875
61
0.405945
0.286987
15
0
0
no
0.5
0.5
no dnr
38
105
7.199219
120
10
37.79688
435
2.899902
24
3.5
145
7.479492
180
72
4,645
null
6
no(M2 and SIP pres)
6
833
0
74.46399
male
1
6
ARF/MOSF w/Sepsis
ARF/MOSF
4
12
under $11k
37
44,037
17,919.9219
20,975.6094
42
white
55.398438
77
0.004
0
1
1
0
no
0.9
0.8
dnr after sadm
5
40
28.898438
75
36
35.19531
64.70312
3.099609
null
6.899414
125
7.479492
254
115
3,345
1
1
<2 mo. follow-up
1
6
1
60.06799
male
0
122
ARF/MOSF w/Sepsis
ARF/MOSF
1
null
null
0
838,218
null
null
34.75
asian
29.796875
57
0.73291
0.649902
1
0
0
no
0.5
0.3
no dnr
122
64
9.298828
134
26
38
null
1.799805
1.899902
1.699951
123
null
152
53
1,825
null
null
null
3.109375
273
1
63.37
male
0
19
ARF/MOSF w/Sepsis
ARF/MOSF
0
null
null
0
140,411
28,087.625
41,106.7812
19
hispanic
21.097656
30
0.792969
0.724976
21
0
0
no
1
0.95
no dnr
19
72
8.699219
60
34
37.89844
null
null
null
0.799927
126
null
null
28
1,585
null
0
Coma or Intub
0
825
0
66.77594
male
0
7
CHF
COPD/CHF/Cirrhosis
5
null
null
0
13,271
6,757
7,582.87891
10.5
white
25.597656
30
0.73291
0.581909
1
1
0
yes
0.7
0.6
no dnr
7
77
6.599609
78
24
36.59375
406.0625
2.899902
null
2.899902
131
7.449219
162
53
2,500
null
null
null
3.947754
575
1
27.12099
female
0
17
ARF/MOSF w/Sepsis
ARF/MOSF
0
20
$25-$50k
0
69,535
30,965.4531
26,185.7969
20
hispanic
30.5
38
0.827881
0.769897
2
0
0
no
0.3
0.1
no dnr
17
63
5.5
122
32
35.79688
195.90625
1.799805
0.199982
0.699951
128
7.389648
82
8
3,660
1
2
null
2
364
1
77.40497
female
0
11
Colon Cancer
Cancer
2
18
>$50k
0
39,468
19,193.3906
21,238.7656
12.5
white
14.099609
5
0.832886
0.635986
1
0
0
metastatic
0.95
0.5
no dnr
11
81
18.699219
76
20
38.19531
null
null
null
1
137
null
171
8
3,300
0
0
no(M2 and SIP pres)
0
243
1
78.55695
male
0
81
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
$11-$25k
37
487,176
null
null
42.75
asian
34.796875
55
0.273987
0.165985
3
0
1
no
0.75
0.75
no dnr
81
55
16.199219
175
12
39
65
null
null
1.099854
134
7.219727
121
21
1,840
null
0
adl>=4 (>=5 if sur)
0
82
1
40.84598
male
0
14
Cirrhosis
COPD/CHF/Cirrhosis
6
13
$11-$25k
0
33,793
16,031.2656
17,976.6094
16
white
27.5
40
0.783936
0.653931
1
1
0
no
0.8
0.33
no dnr
14
99
7.299805
130
24
38.39844
null
2.699707
6.399414
1.699951
131
null
199
21
740
1
null
null
1.166748
820
0
66.27496
male
0
10
MOSF w/Malig
ARF/MOSF
1
14
null
37
69,356
16,043.1875
14,909.5547
25.5
black
28.296875
31
0.242981
0.140991
7
0
0
metastatic
0.5
0.3
no dnr
10
130
12.798828
124
24
36
150
null
null
1.299805
145
7.449219
null
21
2,100
null
1
<2 mo. follow-up
1
39
1
61.59598
male
0
8
CHF
COPD/CHF/Cirrhosis
3
15
>$50k
0
32,311
16,214.0234
20,290.4844
24
white
23.699219
32
0.829956
0.7229
1
0
0
no
0.9
0.8
no dnr
8
55
7.099609
135
24
36.59375
null
null
null
1.299805
135
null
null
13
500
0
0
null
0
818
0
88.18298
female
0
7
CHF
COPD/CHF/Cirrhosis
3
null
null
0
25,625
13,662.4531
12,145.1094
11.5
white
18.796875
22
0.750977
0.606934
1
0
1
yes
0.5
0.2
no dnr
7
70
5.899414
65
28
36.5
187.75
null
null
1.199951
142
7.439453
179
17
1,480
null
null
null
4.939453
817
0
59.48499
male
0
12
CHF
COPD/CHF/Cirrhosis
2
12
$25-$50k
0
52,138
25,009.7969
23,588.7188
24
white
26.597656
40
0.79895
0.675903
1
0
0
no
0.6
0.4
no dnr
12
63
10.898438
125
30
36
238.09375
null
1.399902
0.799927
131
7.469727
120
22
1,660
0
0
no(M2 and SIP pres)
0
547
1
50.66898
male
0
21
Colon Cancer
Cancer
1
null
null
0
76,684
33,434.1875
33,963.6875
20
white
20.5
13
0.794922
0.566895
1
0
0
metastatic
null
null
no dnr
21
71
7.699219
72
24
36.39844
null
3
0.699951
1.099854
134
null
85
13
2,400
null
null
null
2.794922
410
1
29.02399
female
0
94
ARF/MOSF w/Sepsis
ARF/MOSF
0
10
under $11k
0
null
357,422.5
505,211
52.25
hispanic
56
92
0.16098
0.078995
7
0
0
no
0.2
0.2
no dnr
94
42
13.898438
135
25
39.09375
128
null
22.796875
3.799805
141
7.609375
72
57
0
null
0
adl>=4 (>=5 if sur)
0
816
0
76.80194
female
1
109
ARF/MOSF w/Sepsis
ARF/MOSF
1
10
$11-$25k
26
1,226,766
386,508
528,444
46.25
white
31
63
0.379944
0.261963
18
1
0
no
0.5
0.5
dnr after sadm
13
55
13.298828
70
10
38.79688
140
null
null
3.699707
146
7.519531
null
67
0
null
0
Coma or Intub
0
109
1
83.93994
male
0
10
CHF
COPD/CHF/Cirrhosis
3
14
>$50k
0
79,139
34,448.9375
36,685.6875
34.5
white
15.099609
35
0.858887
0.767944
1
1
0
no
0.8
0.7
no dnr
10
62
12.199219
75
8
38.09375
285
null
null
1.5
138
7.429688
255
38
2,674
0
0
no(M2 and SIP pres)
0
327
1
91.61896
male
0
5
Coma
Coma
2
12
null
55
10,709
5,111.0938
6,091.73828
12
white
13
17
0.485962
0.41394
1
0
1
no
0.2
0.15
dnr before sadm
-1
69
10.398438
80
24
38
null
null
null
1
140
null
null
10
1,125
null
7
adl>=4 (>=5 if sur)
7
172
1
29.76299
female
0
42
ARF/MOSF w/Sepsis
ARF/MOSF
4
13
under $11k
0
296,857
107,396.188
119,722.5
38
white
35.296875
62
0.723999
0.638916
4
1
0
no
0.9
0.9
no dnr
42
112
12.699219
115
35
38.09375
92.53125
3.799805
null
7.299805
147
7.269531
212
70
730
null
0
adl>=4 (>=5 if sur)
0
146
1
58.60599
female
0
25
ARF/MOSF w/Sepsis
ARF/MOSF
3
15
>$50k
26
538,323
52,945.7812
48,681.0938
36.5
asian
29.898438
61
0.520996
0.404968
48
0
0
no
0.6
0.5
no dnr
25
57
10
115
34
37.79688
323.3125
4.099609
1.5
2
128
7.5
156
58
2,708
null
0
no(M2 and SIP pres)
0
103
1
40.78
male
0
19
ARF/MOSF w/Sepsis
ARF/MOSF
2
18
$11-$25k
0
105,330
47,823.3438
61,883.25
32
white
24
32
0.873901
0.829956
1
0
0
no
0.8
0.8
no dnr
19
58
5
115
10
38.89844
234
null
1.599854
1.099854
132
7.459961
76
12
3,055
null
0
no(M2 and SIP pres)
0
814
0
92.64294
male
1
7
ARF/MOSF w/Sepsis
ARF/MOSF
1
18
null
0
26,196
11,135.9531
12,108.6172
11.5
white
48.09375
80
0.074997
0.028
1
0
1
no
0.1
0.1
dnr after sadm
1
33
27
165
15
36
98.32812
3.399902
1.099854
1.099854
139
7.469727
null
20
45
null
0
<2 mo. follow-up
0
7
1
45.80197
female
0
21
ARF/MOSF w/Sepsis
ARF/MOSF
0
16
>$50k
0
215,484
108,049.5
98,066.1875
44.666657
hispanic
31.296875
44
0.764893
0.689941
1
0
0
no
null
null
no dnr
21
57
22.5
65
25
39.19531
97.14062
3.399902
0.599976
1.099854
128
7.449219
106
11
4,770
null
null
no(M2 and SIP pres)
2.28418
811
0
54.52399
female
1
7
MOSF w/Malig
ARF/MOSF
1
12
$25-$50k
26
263,308
42,022.6875
42,821.0938
52
white
40.398438
70
0.064987
0.022999
36
0
0
yes
0.1
0.05
no dnr
7
115
0.049995
175
38
39.5
495.8125
2.699707
7.399414
0.599976
151
7.549805
183
24
2,120
null
0
<2 mo. follow-up
0
7
1
77.85895
male
0
6
CHF
COPD/CHF/Cirrhosis
5
null
null
0
13,403
7,402.2422
6,417.01953
9
white
19.097656
21
0.791992
0.665894
1
0
0
yes
0.8
0.7
no dnr
6
83
6.399414
76
28
35.59375
null
3.599609
1.299805
1.599854
140
null
null
25
2,075
null
null
null
3.035156
294
1
30.53799
male
0
5
Lung Cancer
Cancer
1
20
>$50k
0
17,851
7,609.7148
8,499.28906
11
white
16.699219
11
0.785889
0.550903
1
0
0
metastatic
1
0.75
no dnr
5
101
16.699219
100
20
36.19531
null
3.399902
0.199982
0.899902
135
null
86
11
7,800
0
null
null
0.494751
235
1
66.05597
male
1
19
ARF/MOSF w/Sepsis
ARF/MOSF
1
null
null
0
283,022
56,063.75
60,610.5625
34.666657
white
33.796875
78
0.513916
0.396973
14
0
0
no
0.4
0.4
dnr after sadm
13
108
38.898438
45
28
36
377.75
2.699707
5.199219
6.799805
133
7.509766
140
57
30
null
null
<2 mo. follow-up
3.158691
19
1
49.42398
female
0
79
ARF/MOSF w/Sepsis
ARF/MOSF
2
18
$25-$50k
26
809,561
312,729
321,893.5
37.25
white
31.398438
53
0.657959
0.559937
1
0
0
no
0.1
0.5
dnr after sadm
42
45
5.599609
105
33
38
304
2.099609
1.5
1.799805
140
7.429688
126
66
2,705
null
0
adl>=4 (>=5 if sur)
0
118
1
47.93399
female
0
12
MOSF w/Malig
ARF/MOSF
2
16
$25-$50k
0
64,713
27,221.6719
24,035.0469
16.5
asian
36.898438
48
0.393982
0.274963
1
0
0
yes
0.95
0.7
no dnr
12
85
30.199219
65
34
36.29688
86.65625
null
null
3.699707
131
7.389648
119
41
1,535
0
0
no(M2 and SIP pres)
0
809
0
77.28998
male
0
4
CHF
COPD/CHF/Cirrhosis
3
12
$11-$25k
0
4,408
2,348.4766
2,657.63867
8
white
19.597656
21
0.827881
0.718994
1
0
0
no
0.9
0.8
no dnr
4
65
5.799805
68
16
36
null
null
null
1.399902
130
null
null
26
3,220
0
null
no(M2 and SIP pres)
0.494751
809
0
58.14398
male
0
10
CHF
COPD/CHF/Cirrhosis
2
12
under $11k
0
32,904
18,238.0312
17,585.1094
20
hispanic
16
32
0.911987
0.850952
1
0
0
no
0.8
0.7
no dnr
10
57
9.099609
70
24
36.5
null
3.699707
0.599976
1.799805
136
null
102
25
4,050
0
null
no(M2 and SIP pres)
0.494751
540
1
58.09399
male
0
13
MOSF w/Malig
ARF/MOSF
1
14
null
44
75,939
27,794.0156
30,730.8125
35
white
26.5
44
0.287964
0.177979
5
0
0
metastatic
0.2
0.1
no dnr
13
62
13.398438
120
20
36.39844
null
null
0.899902
2.199707
134
null
72
54
1,207
null
0
<2 mo. follow-up
0
47
1
69.79895
female
1
7
ARF/MOSF w/Sepsis
ARF/MOSF
3
16
$11-$25k
41
99,643
26,943.4531
32,321.8594
34.5
white
54.695313
90
0.001
0
12
0
0
no
0
0
dnr after sadm
6
45
17.398438
115
24
35.59375
130.96875
2.5
17.796875
2.399902
129
7.459961
97
50
80
null
0
<2 mo. follow-up
0
7
1
24.98299
female
0
11
ARF/MOSF w/Sepsis
ARF/MOSF
2
18
under $11k
0
37,548
18,954.5469
19,909.5
20.5
white
29.398438
43
0.85791
0.80896
1
0
0
no
0.7
0.5
no dnr
11
105
7.399414
125
24
36.59375
null
null
3.199707
3.399902
132
null
102
98
2,920
1
0
null
0
98
1
67.98395
male
0
9
Lung Cancer
Cancer
2
16
>$50k
0
31,422
15,106.75
13,609.6172
14.5
white
19.296875
20
0.652954
0.347961
1
0
0
metastatic
0.8
0.4
no dnr
9
64
7.599609
66
24
36
226.65625
null
null
1.399902
131
7.519531
null
16
2,770
2
null
<2 mo. follow-up
1.838867
21
1
31.94299
female
0
9
CHF
COPD/CHF/Cirrhosis
3
12
$11-$25k
0
27,706
14,902.0469
14,508.5938
14
white
20
21
0.930908
0.882935
1
0
0
no
0.95
0.9
no dnr
9
53
7.299805
105
16
36.39844
null
3.799805
0.199982
0.799927
138
null
null
16
2,250
2
2
null
2
804
0
54.461
male
1
15
ARF/MOSF w/Sepsis
ARF/MOSF
2
16
>$50k
44
256,932
67,671.25
76,761.125
53.666657
white
36.09375
72
0.385986
0.267944
2
0
0
no
0.5
0.5
no dnr
15
107
44.796875
135
28
37.89844
356.625
null
12.798828
3.599609
142
7.519531
191
90
3,875
null
3
<2 mo. follow-up
3
15
1
63.91199
female
0
3
CHF
COPD/CHF/Cirrhosis
3
18
>$50k
0
3,241
1,547.0508
1,810.36914
6
white
19.699219
34
0.86792
0.781982
1
1
0
no
0.95
0.65
no dnr
3
107
9.798828
68
20
36.5
null
3.399902
0.199982
2.399902
139
null
151
48
875
4
null
null
3.183106
803
0
58.15698
male
0
4
CHF
COPD/CHF/Cirrhosis
4
12
under $11k
0
8,082
3,576.2227
4,990.80859
10
white
16.097656
10
0.910889
0.849976
1
1
0
no
null
null
no dnr
4
72
11.199219
75
20
36.19531
null
null
0.599976
1.299805
139
null
112
18
2,390
null
null
no(M2 and SIP pres)
2.447266
800
0
48.05698
female
0
4
ARF/MOSF w/Sepsis
ARF/MOSF
1
null
null
26
22,509
9,981.5703
10,215.9141
26
black
23.5
41
0.806885
0.74292
1
1
0
no
0.9
0.85
no dnr
4
130
13.699219
95
28
38.19531
323.75
null
0.5
3.5
137
7.449219
151
47
2,140
null
null
null
3.416016
202
1
76.23798
male
0
7
CHF
COPD/CHF/Cirrhosis
2
16
$11-$25k
0
22,612
11,324.4766
10,989.5781
20.5
white
20.199219
25
0.823975
0.713989
1
1
0
no
0.95
0.9
no dnr
7
65
11.298828
55
20
38.09375
173.46875
null
null
1.299805
135
7.389648
276
25
1,875
0
0
null
0
569
1
50.29999
female
0
93
ARF/MOSF w/Sepsis
ARF/MOSF
2
6
under $11k
37
589,642
179,035.25
235,552.125
35.75
hispanic
47.59375
66
0.092987
0.036995
7
0
0
no
0.5
0.5
no dnr
93
70
21.199219
120
26
36.09375
115.54688
2.699707
38.09375
1.599854
131
7.469727
212
51
2,786
null
null
SIP>=30
3.131836
798
0
32.25699
male
0
8
Colon Cancer
Cancer
1
null
null
0
15,115
9,239.3906
9,923.58594
14.5
white
14.599609
8
0.890991
0.750977
1
0
0
metastatic
1
1
no dnr
8
78
5.5
68
20
36.39844
null
null
null
null
140
null
null
null
2,150
null
null
null
2.458984
427
1
80.87299
female
0
13
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
$25-$50k
44
47,516
20,618.8281
18,296.7188
28.5
white
23
27
0.60498
0.497986
1
0
1
no
0.5
0.5
no dnr
13
68
9.199219
65
28
38.5
112.23438
null
null
0.699951
138
7.329102
179
9
900
null
7
null
7
797
0
35.50198
female
0
14
ARF/MOSF w/Sepsis
ARF/MOSF
2
14
under $11k
26
86,275
36,490.5
38,960.2188
25.666656
black
33.898438
50
0.674927
0.580933
1
0
0
no
0.3
0.3
no dnr
14
68
2.699707
115
26
39.5
118.51562
3.399902
2.199707
1.199951
136
7.539062
174
24
3,550
null
null
no(M2 and SIP pres)
3.861328
796
0
65.32495
male
1
4
ARF/MOSF w/Sepsis
ARF/MOSF
2
12
$25-$50k
37
51,732
20,733.4062
28,262.6406
66
white
40.695313
84
0.23999
0.13797
1
0
0
no
0.2
0.1
no dnr
4
52
8.898438
175
10
38.79688
204
null
22.199219
4.299805
140
7.319336
78
80
760
null
null
<2 mo. follow-up
3.147949
4
1
67.72296
male
0
4
CHF
COPD/CHF/Cirrhosis
5
12
null
0
10,358
5,064.6758
4,503.01953
14
white
15.5
23
0.868896
0.782959
1
0
0
yes
0.8
0.7
no dnr
4
63
5.399414
80
24
36
null
null
null
1.199951
136
null
100
33
1,620
1
null
no(M2 and SIP pres)
1.166748
158
1
65.02899
female
0
7
Coma
Coma
1
12
null
37
64,130
33,178.5938
32,269.2969
19
white
19.597656
23
0.566895
0.5
1
0
0
yes
0.85
0.8
no dnr
7
98
12.798828
55
28
37.89844
300
null
null
0.599976
138
7.5
263
14
5,420
null
0
adl>=4 (>=5 if sur)
0
795
0
84.25995
male
0
7
ARF/MOSF w/Sepsis
ARF/MOSF
2
14
under $11k
9
26,395
10,339.2344
10,321.625
12
white
22.199219
39
0.717896
0.631958
2
0
0
no
0.5
0.2
dnr before sadm
0
74
7.799805
118
12
36.39844
null
null
null
1.599854
136
null
77
26
970
null
6
<2 mo. follow-up
6
14
1
34.47198
male
0
4
ARF/MOSF w/Sepsis
ARF/MOSF
0
null
null
26
19,858
8,356.9141
9,044.44531
24
white
18.796875
23
0.892944
0.85498
1
0
0
no
0.9
0.9
no dnr
4
83
8.699219
105
32
36.59375
247.59375
null
null
0.899902
135
7.5
149
16
1,000
null
null
null
2.893066
790
0
42.24197
male
0
6
CHF
COPD/CHF/Cirrhosis
3
13
under $11k
0
22,158
11,588.9922
9,948.35938
26
white
20.5
24
0.909912
0.848999
1
0
0
no
1
0.99
no dnr
6
66
7.699219
115
20
35.89844
null
3.799805
1.799805
0.899902
133
null
103
17
5,250
0
0
null
0
789
0
44.00299
male
0
5
Lung Cancer
Cancer
1
12
$11-$25k
0
9,377
5,006.668
6,341.90625
16
hispanic
17.898438
12
0.738892
0.471985
1
0
0
metastatic
0.85
0.5
no dnr
5
95
10.099609
100
22
36.5
null
null
0.199982
0.799927
134
null
null
13
1,900
1
null
SIP>=30
1.166748
176
1
87.48798
male
0
17
CHF
COPD/CHF/Cirrhosis
3
null
null
0
102,946
44,206.9688
43,716.25
9.666664
white
22.199219
20
0.688965
0.521973
1
0
0
yes
null
null
no dnr
17
70
7.099609
55
20
36
null
null
null
1
127
null
182
16
880
null
null
null
4.280273
463
1
82.33496
female
1
14
Coma
Coma
2
14
$25-$50k
44
29,987
17,060.0938
13,291.0391
6.666664
white
21.597656
27
0.385986
0.311951
1
0
1
no
0.2
0.05
dnr after sadm
2
113
36.09375
116
22
38.89844
null
null
null
0.899902
136
null
112
11
425
null
null
<2 mo. follow-up
5.554688
14
1
56.58298
female
0
24
CHF
COPD/CHF/Cirrhosis
4
11
under $11k
0
150,141
81,014.3125
70,802.75
25.333328
white
12.898438
22
0.932983
0.885986
1
1
0
no
0.9
0.85
no dnr
24
72
6.5
75
16
36.19531
null
4
0.399963
1.5
136
null
87
29
3,225
null
1
no(M2 and SIP pres)
1
787
0
18.11899
male
1
8
MOSF w/Malig
ARF/MOSF
2
12
under $11k
41
262,520
47,710.1562
49,025.6875
51.5
white
31.097656
74
0.276978
0.168976
27
0
0
yes
0.04
0
dnr after sadm
7
62
0.199982
130
30
38.69531
347.8125
1.699951
null
0.899902
155
7.349609
null
27
5,565
null
0
<2 mo. follow-up
0
8
1
67.61395
female
0
42
ARF/MOSF w/Sepsis
ARF/MOSF
2
12
$25-$50k
26
212,194
79,058.5625
117,280.812
27
white
25.097656
33
0.610962
0.504883
15
0
0
no
0.2
0.02
no dnr
42
105
11.599609
105
8
37.89844
308.5625
null
1.899902
2.5
133
7.569336
584
39
4,630
1
1
SIP>=30
1
784
0
39.53699
female
0
9
ARF/MOSF w/Sepsis
ARF/MOSF
2
13
$25-$50k
0
50,949
13,308.4609
17,073.2656
21
white
26.796875
27
0.787964
0.718994
3
0
0
yes
0.99
0.99
no dnr
9
105
12.5
75
45
37.89844
128.5625
null
null
0.599976
132
7.459961
124
7
2,850
0
0
no(M2 and SIP pres)
0
784
0
34.103
female
0
53
CHF
COPD/CHF/Cirrhosis
2
12
under $11k
0
401,408
176,795.375
156,396.75
25.75
hispanic
31.699219
31
0.822998
0.711914
1
0
0
no
0.85
0.75
no dnr
53
48
11.699219
120
16
36
423.75
null
null
0.899902
131
7.469727
107
17
2,725
0
0
no(M2 and SIP pres)
0
417
1
85.53595
male
1
11
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
$11-$25k
0
49,143
20,626.4219
19,262.9375
25.5
white
31.796875
50
0.549927
0.435974
1
0
1
no
0.2
0.01
dnr after sadm
3
57
18.097656
112
40
36.29688
171.40625
null
null
1.799805
143
7.389648
160
33
1,100
null
null
<2 mo. follow-up
5.847656
11
1
73.26996
female
0
6
COPD
COPD/CHF/Cirrhosis
3
4
under $11k
0
16,373
8,049.2344
7,158.35938
18
white
19.699219
30
0.827881
0.719971
1
0
0
no
0.5
0.3
no dnr
6
62
16
64
24
36.19531
209.5
null
0.299988
0.599976
141
7.339844
139
11
1,630
null
2
<2 mo. follow-up
2
39
1
48.42697
female
0
11
ARF/MOSF w/Sepsis
ARF/MOSF
2
null
null
26
49,165
null
null
25
white
26
37
0.766968
0.691895
1
0
0
no
0.95
0.95
no dnr
11
102
14.398438
105
35
38.5
156
2.399902
null
0.599976
144
7.479492
154
8
3,140
null
null
null
3.776856
779
0
61.37698
male
0
49
Cirrhosis
COPD/CHF/Cirrhosis
6
12
$25-$50k
9
341,731
173,828.875
190,491.625
34.5
white
47.59375
69
0.07399
0.011
1
0
0
no
0.1
0
no dnr
49
53
14
110
24
36.5
148.96875
3
35
6.399414
148
7.469727
109
71
450
null
null
SIP>=30
3.89502
779
0
41.487
male
0
11
Colon Cancer
Cancer
1
null
null
0
37,940
15,992.1094
14,087.5547
19
black
7.399414
20
0.930908
0.837891
1
0
0
metastatic
null
null
no dnr
11
108
3.5
135
24
37.89844
null
4.5
null
1.299805
139
null
90
12
3,021
null
null
null
2.162109
777
0
66.91595
male
1
23
ARF/MOSF w/Sepsis
ARF/MOSF
2
12
$11-$25k
44
178,495
43,826.0312
43,129.8125
29.333328
white
24.296875
21
0.497986
0.379944
7
1
0
yes
0.5
0.3
dnr after sadm
15
102
17.296875
55
6
39.39844
null
null
null
0.899902
125
null
353
14
1,433
null
null
<2 mo. follow-up
3.083984
23
1
31.20299
male
0
31
ARF/MOSF w/Sepsis
ARF/MOSF
0
17
$25-$50k
0
209,845
70,183.0625
70,860.625
28
other
33.59375
47
0.72998
0.646973
8
0
0
no
1
1
no dnr
31
115
17.699219
145
28
40
138
null
2.299805
0.899902
130
7.459961
113
7
4,995
null
0
null
0
776
0
73.00195
male
0
8
ARF/MOSF w/Sepsis
ARF/MOSF
1
16
>$50k
37
50,658
19,138.6406
23,134.375
27
white
16.796875
25
0.789917
0.720947
1
1
0
no
0.6
0.6
no dnr
8
62
8.199219
70
30
38.39844
308.5625
null
1.099854
1.199951
129
7.449219
368
18
2,450
1
1
no(M2 and SIP pres)
1
775
0
27.187
male
0
14
ARF/MOSF w/Sepsis
ARF/MOSF
6
12
null
41
110,216
40,231.3125
44,875.4062
34.666657
hispanic
30.097656
71
0.705933
0.616943
3
1
0
no
0.7
0.7
no dnr
14
55
7.699219
125
10
36
448
2.299805
0.299988
4.599609
133
7.40918
597
59
220
null
1
no(M2 and SIP pres)
1
774
0
50.064
male
0
7
CHF
COPD/CHF/Cirrhosis
2
null
null
0
13,088
7,913.6211
5,963.29688
13
white
26.199219
30
0.837891
0.734985
1
0
0
no
null
null
no dnr
7
55
8.5
60
16
36
null
null
null
1.5
127
null
null
31
3,900
null
null
null
2.366211
774
0
41.42599
male
0
17
ARF/MOSF w/Sepsis
ARF/MOSF
3
12
$25-$50k
41
275,961
39,765.25
49,991.25
31.666656
white
28.296875
41
0.631958
0.528931
10
0
0
no
0.8
0.8
no dnr
17
102
21.597656
125
28
37.89844
387.5
2.099609
4.899414
0.399963
142
7.479492
128
19
4,210
2
2
no(M2 and SIP pres)
2
773
0
69.25397
female
1
6
Coma
Coma
0
16
$11-$25k
44
52,100
21,710.7344
21,980.125
38
white
23.097656
47
0.475952
0.402954
1
0
0
no
0.3
0.15
dnr after sadm
6
128
19.296875
115
8
38
423
null
null
1.799805
133
7.489258
400
39
2,720
null
0
<2 mo. follow-up
0
6
1
64.54498
male
0
11
CHF
COPD/CHF/Cirrhosis
2
9
under $11k
0
36,225
15,928.9453
13,840
33.5
white
30.5
44
0.707886
0.547974
1
0
0
no
0.75
0.7
no dnr
11
50
6.099609
60
16
36.5
null
null
null
3.099609
131
null
null
65
1,550
null
null
null
3.271973
772
0
47.30499
male
1
5
ARF/MOSF w/Sepsis
ARF/MOSF
4
14
$11-$25k
100
570,603
26,905.0469
26,849.7969
50
white
41.296875
83
0.024998
0.006
22
0
0
no
0.2
0.7
no dnr
5
62
5.899414
145
32
39.19531
122.09375
2.5
13.699219
2.5
145
7.489258
140
115
2,515
null
null
<2 mo. follow-up
4.655273
5
1
72.82697
male
0
3
CHF
COPD/CHF/Cirrhosis
3
12
$11-$25k
0
7,619
3,621.5
3,879.00977
6
black
16.898438
40
0.870972
0.786987
1
0
0
no
null
null
no dnr
3
77
7.299805
85
18
36.69531
null
null
0.799927
1.899902
138
null
94
30
200
0
0
SIP>=30
0
763
0
78.90497
male
0
6
CHF
COPD/CHF/Cirrhosis
2
10
null
0
19,787
8,015.1484
9,785.47656
17
white
19.296875
22
0.826904
0.716919
1
0
0
no
0.99
0.9
no dnr
6
62
6.5
115
24
36.19531
null
null
null
1.099854
138
null
null
12
1,125
0
0
null
0
255
1
53.45697
female
0
19
ARF/MOSF w/Sepsis
ARF/MOSF
0
14
$25-$50k
100
148,758
52,709.4375
56,150.5625
35.666657
black
37.59375
53
0.075989
0.028
4
0
0
no
0.2
0.2
no dnr
19
62
11.798828
105
15
38.5
246.65625
2.699707
36
3.799805
134
7.5
130
61
6,365
null
0
no(M2 and SIP pres)
0
761
0
34.439
female
0
7
MOSF w/Malig
ARF/MOSF
3
12
null
0
53,540
14,613.5
16,389.3125
15.5
black
29.796875
29
0.572998
0.462952
3
0
0
yes
0.8
0.7
no dnr
7
118
2.399902
112
12
36.39844
189
null
0.599976
1.299805
134
7.529297
null
15
2,200
0
0
null
0
761
0
52.36099
male
0
5
CHF
COPD/CHF/Cirrhosis
2
14
under $11k
0
18,956
9,016.3672
7,591.71875
18
white
18.5
41
0.904907
0.839966
1
0
0
no
0.8
0.5
no dnr
5
68
16.398438
110
22
36.5
null
4.599609
null
2.599609
141
null
139
125
4,050
0
0
no(M2 and SIP pres)
0
168
1
44.13699
female
0
13
Lung Cancer
Cancer
1
17
$25-$50k
0
84,983
38,717.2812
35,556.5
33
white
25.898438
40
0.559937
0.237976
1
0
0
metastatic
0.5
0.2
no dnr
13
92
13
110
26
35.59375
257.125
null
null
0.599976
134
7.5
128
20
820
null
null
null
3.5
68
1
77.53595
male
0
12
COPD
COPD/CHF/Cirrhosis
1
null
null
26
100,611
39,571.0938
39,441.2188
35
white
27
45
0.56189
0.365967
1
0
0
no
0.8
0.7
no dnr
12
57
18.296875
135
10
38.19531
164
null
0.699951
1.599854
140
7.459961
165
22
2,691
null
null
null
4.237305
761
0
54.61697
male
0
8
Lung Cancer
Cancer
1
14
$25-$50k
0
20,575
10,134.0156
10,377.9062
14.5
white
20.5
32
0.659912
0.356995
1
0
0
metastatic
0.9
0.7
no dnr
8
79
0.299988
60
22
38
null
null
null
0.699951
126
null
null
11
3,250
null
2
no(M2 and SIP pres)
2
300
1
63.767
male
1
8
ARF/MOSF w/Sepsis
ARF/MOSF
5
14
$25-$50k
9
177,499
24,227.2344
22,082.4531
39
white
44.195313
72
0.125977
0.056
10
0
0
yes
0.5
0.1
dnr after sadm
5
62
14.298828
95
25
36.59375
null
null
54.796875
4.599609
132
null
null
78
0
null
null
<2 mo. follow-up
4.482422
8
1
49.21799
female
0
4
MOSF w/Malig
ARF/MOSF
2
16
>$50k
0
21,363
6,401.5273
6,647.64844
21
white
26.597656
67
0.644897
0.543945
2
0
0
yes
0.05
0.05
dnr after sadm
2
67
41.195313
158
34
36.39844
280
null
null
1.199951
131
7.5
83
25
300
null
null
<2 mo. follow-up
2.286133
9
1
86.83099
female
1
12
ARF/MOSF w/Sepsis
ARF/MOSF
1
null
null
26
83,218
26,476.1719
31,744.4219
36.5
white
45.195313
62
0.056999
0.018997
2
0
0
no
0.25
0.2
dnr after sadm
6
37
15.599609
65
10
38.59375
126.65625
null
null
3.699707
131
7.479492
null
63
1,088
null
5
<2 mo. follow-up
5
12
1
46.56799
male
0
9
ARF/MOSF w/Sepsis
ARF/MOSF
2
null
null
0
95,981
17,189.0625
17,722.0156
15
white
26.898438
42
0.777954
0.705933
10
0
0
no
0.7
0.5
no dnr
9
70
15.599609
125
16
36.5
null
null
null
2.099609
133
null
202
78
4,360
null
null
<2 mo. follow-up
3.291016
16
1
58.431
male
0
16
ARF/MOSF w/Sepsis
ARF/MOSF
4
13
$25-$50k
26
97,332
36,308.8125
38,937.0312
32.666657
white
33.59375
64
0.55188
0.437988
1
1
0
no
0.3
0.15
no dnr
16
110
15
115
31
35.89844
323.3125
2.399902
3.399902
2.699707
131
7.379883
356
94
4,225
null
0
no(M2 and SIP pres)
0
360
1
74.49396
female
1
4
ARF/MOSF w/Sepsis
ARF/MOSF
1
16
null
61
56,321
6,909.1641
8,393.32812
15
white
27.5
56
0.18399
0.095993
7
0
0
metastatic
0.75
0.5
dnr after sadm
2
60
39.195313
120
30
37.29688
151
null
0.699951
1.399902
142
7.369141
244
27
175
null
null
<2 mo. follow-up
3.899902
4
1
47.17599
female
1
73
MOSF w/Malig
ARF/MOSF
1
14
>$50k
26
915,302
null
null
39.5
white
31.097656
63
0.292969
0.182983
3
0
0
metastatic
0.9
0.7
no dnr
73
110
8.5
125
28
36.09375
191.09375
null
1.5
5.199219
134
7.429688
159
63
106
null
0
null
0
73
1
71.42499
female
1
7
Cirrhosis
COPD/CHF/Cirrhosis
5
null
null
44
60,990
23,809.3594
29,152.3906
36
white
39.398438
62
0.048996
0.004999
1
1
0
no
0.2
0.1
dnr after sadm
3
55
13.599609
55
26
35.69531
120.75
1.299805
8.699219
0.599976
148
7.489258
124
15
2,990
null
null
<2 mo. follow-up
4.235352
7
1
52.84097
female
0
40
ARF/MOSF w/Sepsis
ARF/MOSF
2
14
$25-$50k
26
283,898
139,695.125
152,409.25
27.75
white
20.097656
10
0.823975
0.764893
2
0
0
no
0.9
0.8
no dnr
40
108
11.199219
105
10
38.69531
405
2.699707
1.599854
0.699951
135
7.459961
168
17
2,728
5
7
null
7
749
0
65.81
male
0
4
Lung Cancer
Cancer
2
18
$25-$50k
0
14,638
7,570.957
7,596.67969
13
white
23.097656
27
0.563965
0.241974
1
0
0
metastatic
0.1
0.1
no dnr
4
79
7.299805
136
22
38.39844
null
null
null
1.299805
127
null
96
12
720
0
0
null
0
92
1
20.991
male
0
8
ARF/MOSF w/Sepsis
ARF/MOSF
3
13
>$50k
26
69,111
22,133.0781
23,038.3594
22
white
26.597656
63
0.828979
0.771973
3
0
0
no
1
0.9
no dnr
8
65
17.398438
95
26
38.5
135
null
0.399963
10
146
7.439453
155
40
0
0
0
null
0
747
0
79.56696
female
1
10
Coma
Coma
4
null
null
61
54,981
17,895.0156
17,097.8281
28
white
16.199219
17
0.30896
0.237976
7
1
0
yes
0
0
dnr after sadm
9
107
20.898438
70
14
38.39844
435
null
null
0.799927
134
7.549805
null
10
1,620
null
null
<2 mo. follow-up
3.219238
10
1
42.36798
male
0
7
CHF
COPD/CHF/Cirrhosis
2
12
$25-$50k
0
26,673
13,993.6328
12,473.7891
15
white
25.796875
31
0.86499
0.776978
1
0
0
no
null
null
no dnr
7
55
9.199219
110
20
36.19531
null
3.699707
0.899902
1.399902
128
null
103
22
3,225
0
0
null
0
747
0
72.06299
female
0
4
CHF
COPD/CHF/Cirrhosis
4
9
null
0
6,761
3,211.4473
3,179.79883
3
hispanic
25.296875
39
0.765991
0.62793
1
1
0
no
0.9
0.75
no dnr
4
123
6.399414
82
26
36.39844
null
2.5
null
2
138
null
242
25
1,600
1
1
null
1
747
0
84.04895
female
0
15
ARF/MOSF w/Sepsis
ARF/MOSF
0
null
null
44
63,995
24,024.3125
22,687.4062
16
white
24.796875
39
0.492981
0.375977
3
0
0
no
0.1
0.05
dnr after sadm
6
62
23.699219
65
42
36.09375
182.5
null
1
1.099854
150
7.469727
null
54
1,180
null
null
null
4.201172
746
0
41.33899
male
0
8
CHF
COPD/CHF/Cirrhosis
2
null
null
0
27,099
13,704.3828
12,439.6953
14.5
white
17.398438
19
0.930908
0.882935
1
0
0
no
1
0.9
no dnr
8
62
7.599609
115
22
37.5
null
3.599609
0.299988
1.399902
136
null
121
18
3,350
null
null
null
2.926758
664
1
66.22595
male
1
82
ARF/MOSF w/Sepsis
ARF/MOSF
5
18
$25-$50k
37
837,022
327,682.5
303,778.5
44
white
37.09375
54
0.245972
0.142975
8
1
0
no
0.2
0.1
no dnr
82
68
6.599609
110
23
36.19531
312.5
null
26
3
149
7.439453
null
116
1,540
null
2
null
2
82
1